1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (125)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (919)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of recurrence and prognostic factors in endometrial cancer molecular subtypes
    Meeting Abstract

    Lam, C.; Dagher, C.; Ellenson, L. H.; Mueller, J. J.; Weigelt, B.; Abu-Rustum, N.; Momeni-Boroujeni, A.
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Monitoring response to immune checkpoint inhibition in patients with endometrial cancer using cell-free DNA analysis
    Meeting Abstract

    Manning-Geist, B.; Patel, J.; Marra, A.; Zammarrelli, W. A. 3rd; Da Cruz Paula, A.; Abu-Rustum, N.; Shah, R.; Berger, M.; Hensley, M.; Lakhman, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Long survival in patients with adnexal high-grade serous carcinoma who underwent suboptimal cytoreductive surgery: A whole-genome analysis
    Meeting Abstract

    Sullivan, M.; Brown, D.; Paula, A. D.; Boerner, T.; O'Cearbhaill, R.; Tew, W.; Grisham, R.; Sonoda, Y.; Leitao, M.; Broach, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Impact of hyperthermic intraperitoneal chemotherapy at time of secondary cytoreductive surgery on immediate platinum resistance: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Praiss, A.; Donohoe, F.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Broach, V.; Al-Niaimi, A.; Gardner, G.; Roche, K. L.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)
    Meeting Abstract

    Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save